Cereset

Name

Cereset

Legal name

Cereset, LLC

Website

https://cereset.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Brain Wellness Services

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)

akta.pro secondary industry

Neurodiagnostic Centers (EEG/EMG/NCS) (HLAFAKAK)

Keywords

• Acoustic neuromodulation
• Brain wellness services
• Sound therapy
• Stress relief therapy
• Franchise wellness centers

Headquarters

HQ city

Scottsdale

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Client Sessions: Revenue generated from individual client sessions at Cereset client centers. Sessions are provided by certified Tech Coaches and include initial evaluations, baseline brain observations, and ongoing treatment sessions.
2. Franchise Fees: Cereset sells franchise opportunities for entrepreneurs to open and operate Cereset client centers. Franchise owners pay initial fees and ongoing royalties for the right to use the Cereset brand, technology, and operational model.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels11 records

Core offering

Cereset delivers BrainEcho® acoustic neuromodulation sessions through its network of 62+ franchise client centers in the US and internationally. Sensors on the scalp detect the brain's electrical activity, proprietary software translates dominant frequencies into acoustic tones played through earbuds, and the brain hears and responds to its own patterns, enabling natural rebalancing for stress, anxiety, sleep issues, PTSD, and cognitive challenges. The Personal Brain Index® (PBI®) provides a personalized baseline assessment, and Cereset Antiaging™ adds age-specific protocols.

Product overview

Cereset is a wellness company offering a suite of non-invasive brain self-regulation services centered on its patented BrainEcho® acoustic neuromodulation technology. The core product is the BrainEcho® NetworkFlow™ closed-loop system, which detects brain electrical activity via sensors, translates dominant frequencies into acoustic tones, and plays them back through earbuds so the brain hears and responds to its own patterns — facilitating natural self-balancing. This core platform is supported by the Personal Brain Index® (PBI®) assessment, which establishes each client's baseline and informs individualized session plans. Cereset Antiaging™ extends the platform with age-specific protocols targeting cognitive decline. All offerings are delivered through a network of 62+ certified client centers under the guidance of trained Tech Coaches, with the research division (Cereset Research/HIRREM) providing clinical validation across 17 peer-reviewed publications.

Differentiator

Problem solved

Functional benefit

Brands

• BrainEcho®: Patented acoustic neuromodulation technology that mirrors the brain's own electrical activity through sound to enable self-regulation and balance.
• BrainEcho® NetworkFlow™
• Personal Brain Index® (PBI®)
• Cereset Research™
• HIRREM®
• Cereset Antiaging™

Products and services

• BrainEcho® NetworkFlow™ The evolution of Cereset's patented brain-mirroring acoustic neuromodulation technology. A closed-loop system detects brain electrical activity via custom sensors, translates dominant frequencies into acoustic tones played through earbuds, and mirrors the brain's own patterns back to itself to support self-regulation. Designed to improve restorative sleep, stress recovery, emotional balance, and cognitive clarity in individual clients attending Cereset client centers.
• BrainEcho® The foundational patented acoustic neuromodulation process, used inside the Company's earlier generations of Cereset sessions. Custom high-resolution sensors detect the brain's electrical activity in real time, proprietary software translates dominant brain frequencies into acoustic tones, and the tones are played through earbuds so the brain hears its own "echo" and naturally rebalances. Targets stress, anxiety, insomnia, and other conditions at Cereset client centers.
• Personal Brain Index® (PBI®) A personalized brain assessment delivered during the Introduction to Cereset session that measures the client's brain harmony and ability to manage stress. Functions as the diagnostic baseline and informs the individual's recommended plan of action and session cadence.
• Introduction to Cereset A 50-minute evaluation session at a Cereset client center that includes orientation with a personal Tech Coach, a baseline brain observation, generation of the client's Personal Brain Index® (PBI®), and a recommended plan of action. This is the entry-point service for new clients.
• Cereset Antiaging™ A brain-driven antiaging service that applies proprietary BrainEcho® neuromodulation protocols to cerebral cortex regions most vulnerable to age-related thinning. Designed to "exercise" these regions, with claims of improvements in memory, recall, decision-making, learning, focus, and overall cognitive function for aging clients.
• Cereset Research (HIRREM®) The research division and legacy technology of Cereset. HIRREM® (High-resolution, Relational, Resonance-based Electroencephalic Mirroring®) is the research predecessor to BrainEcho®, used in clinical trials at Wake Forest School of Medicine and military institutions (Womack Army Medical Center, Uniformed Services University). Supported by 17 peer-reviewed publications, 80+ abstracts/presentations, IRB-approved clinical trials, and 1,000+ participants, and operating as an integral part of the Brain Body Research Program at Wake Forest University School of Medicine.

Quantifiable outcome

• 72% of participants experienced substantial stress relief within two weeks in randomized controlled trial with 144 healthcare workers at Wake Forest School of Medicine
• +8 more outcomes

Named customers8 records

Segments7 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Partnerships

Eight partnerships are on record, tiered core and supporting.

• Wake Forest School of Medicine - Brain Body Research ProgramcoreStrategic or Co-development PartnerCereset Research is an integral part of the Brain Body Research Program at Wake Forest University School of Medicine. Most of Cereset's clinical research has been conducted at Wake Forest. The partnership has produced 17 peer-reviewed publications and 80+ presentations. Dr. Charles H. Tegeler serves as principal investigator on multiple studies.
• Womack Army Medical CentercoreStrategic or Co-development PartnerClinical research site for evaluating HIRREM/Cereset technology for military personnel with traumatic stress symptoms and mild traumatic brain injury. Conducted studies in partnership with Brain State Technologies and Cereset.
• Uniformed Services University of the Health SciencescoreStrategic or Co-development PartnerResearch partnership for military-related traumatic stress and mild TBI studies. Located at Walter Reed National Military Medical Center in Bethesda, MD.
• Spartanburg Regional Health ServicessupportingStrategic or Co-development PartnerClinical trial site for Cereset research focusing on various health conditions.
• Geneva FoundationsupportingStrategic or Co-development PartnerSub-award recipient in DoD-funded clinical trial for military TBI research alongside Womack Army Medical Center.
• Henry Jackson FoundationsupportingStrategic or Co-development PartnerSub-award recipient in DoD-funded clinical trial alongside Uniformed Services University for military TBI research.
• State of Nevada Department of CorrectionssupportingStrategic or Co-development PartnerClinical research partnership for studying PTSD and education outcomes in inmate population.
• Yavapai County Drug CourtsupportingStrategic or Co-development PartnerResearch partnership for studying drug rehabilitation outcomes.

Scale indicators10 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Muse (Interaxon): Muse makes consumer EEG-based headbands for meditation, sleep, and focus. Like Cereset, it uses real-time brain-sensing feedback to help users self-regulate stress and sleep, but delivers the experience at home via a hardware + app model rather than in-center sessions.
• Apollo Neuro: Apollo Neuro produces a wearable that delivers low-frequency vibrations to modulate the autonomic nervous system for stress, sleep, and focus. It targets the same consumer pain points as Cereset (stress, anxiety, sleep) using a continuous-wear, at-home neuromodulation approach.
• Fisher Wallace: Fisher Wallace manufactures FDA-cleared cranial electrotherapy stimulation devices marketed for insomnia, anxiety, and depression. It competes with Cereset in the consumer neuromodulation category for stress and sleep, with a home-use hardware model.
• BrainCo: BrainCo develops EEG-based wearables (e.g., Focus headband) for attention, meditation, and cognitive performance, and prosthetic control. It overlaps with Cereset in the consumer EEG neurofeedback space, especially for focus and cognitive wellness.
• Emotiv: Emotiv produces multi-channel EEG headsets and a brain-mapping platform used in research, wellness, and performance applications. Its consumer/prosumer EEG hardware competes in the same brain-sensing wellness category as Cereset's BrainEcho sensors.
• Neurable: Neurable builds EEG-based wearables and software for focus, productivity, and brain-computer interface applications. It targets a similar consumer/professional audience seeking EEG-driven cognitive performance benefits, an adjacent category to Cereset's acoustic mirroring.

Broad incumbents

• NeuroPace: NeuroPace makes the RNS System, an implanted responsive neurostimulator for refractory epilepsy. As a clinically validated, FDA-approved neuromodulation company operating in neurology, it represents the institutional, regulated end of the neuromodulation spectrum that Cereset's wellness approach sits adjacent to.
• Neuronetics: Neuronetics markets NeuroStar, a transcranial magnetic stimulation (TMS) system for treatment-resistant depression. It is a clinically validated, FDA-cleared neuromodulation incumbent targeting overlapping conditions (depression, anxiety) but delivered in a clinical setting under prescription.

Emerging players

• Headspace: Headspace is a leading consumer mental wellness and meditation app addressing stress, sleep, and focus. It does not use neuromodulation hardware, but competes for the same end-customer mindshare and discretionary wellness dollars as Cereset, often at a much lower price point.
• Calm: Calm is a subscription-based meditation, sleep, and mental wellness app competing directly with Cereset for consumer attention and wallet share on sleep and stress, but via digital content rather than EEG-based acoustic neuromodulation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/wearecereset
• Facebookfacebook.com/WeAreCereset
• LinkedInlinkedin.com/company/cereset
• Instagraminstagram.com/wearecereset

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cereset